Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs).

Spinelli V, Guillot PV, De Coppi P.

Organogenesis. 2013 Apr-Jun;9(2):101-10. doi: 10.4161/org.25197. Epub 2013 Apr 1. Review.

2.

Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells.

Galende E, Karakikes I, Edelmann L, Desnick RJ, Kerenyi T, Khoueiry G, Lafferty J, McGinn JT, Brodman M, Fuster V, Hajjar RJ, Polgar K.

Cell Reprogram. 2010 Apr;12(2):117-25. doi: 10.1089/cell.2009.0077.

3.
4.

Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.

Li C, Zhou J, Shi G, Ma Y, Yang Y, Gu J, Yu H, Jin S, Wei Z, Chen F, Jin Y.

Hum Mol Genet. 2009 Nov 15;18(22):4340-9. doi: 10.1093/hmg/ddp386. Epub 2009 Aug 13.

5.

Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach.

Moschidou D, Mukherjee S, Blundell MP, Drews K, Jones GN, Abdulrazzak H, Nowakowska B, Phoolchund A, Lay K, Ramasamy TS, Cananzi M, Nettersheim D, Sullivan M, Frost J, Moore G, Vermeesch JR, Fisk NM, Thrasher AJ, Atala A, Adjaye J, Schorle H, De Coppi P, Guillot PV.

Mol Ther. 2012 Oct;20(10):1953-67. doi: 10.1038/mt.2012.117. Epub 2012 Jul 3.

6.

Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells.

Chang G, Miao YL, Zhang Y, Liu S, Kou Z, Ding J, Chen DY, Sun QY, Gao S.

PLoS One. 2010 Apr 26;5(4):e10320. doi: 10.1371/journal.pone.0010320.

7.

Ontological differences in first compared to third trimester human fetal placental chorionic stem cells.

Jones GN, Moschidou D, Puga-Iglesias TI, Kuleszewicz K, Vanleene M, Shefelbine SJ, Bou-Gharios G, Fisk NM, David AL, De Coppi P, Guillot PV.

PLoS One. 2012;7(9):e43395. doi: 10.1371/journal.pone.0043395. Epub 2012 Sep 4.

8.

Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues.

Abdulrazzak H, Moschidou D, Jones G, Guillot PV.

J R Soc Interface. 2010 Dec 6;7 Suppl 6:S689-706. doi: 10.1098/rsif.2010.0347.focus. Epub 2010 Aug 25. Review.

10.

Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.

Tsai SY, Clavel C, Kim S, Ang YS, Grisanti L, Lee DF, Kelley K, Rendl M.

Stem Cells. 2010 Feb;28(2):221-8. doi: 10.1002/stem.281.

11.

Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder-free system.

Lu HE, Tsai MS, Yang YC, Yuan CC, Wang TH, Lin XZ, Tseng CP, Hwang SM.

Exp Cell Res. 2011 Aug 1;317(13):1895-903. doi: 10.1016/j.yexcr.2011.05.017. Epub 2011 May 26.

PMID:
21640101
12.

The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.

Tat PA, Sumer H, Jones KL, Upton K, Verma PJ.

Cell Transplant. 2010;19(5):525-36. doi: 10.3727/096368910X491374. Epub 2010 Feb 8.

PMID:
20144262
13.

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

Abad M, Mosteiro L, Pantoja C, Cañamero M, Rayon T, Ors I, Graña O, Megías D, Domínguez O, Martínez D, Manzanares M, Ortega S, Serrano M.

Nature. 2013 Oct 17;502(7471):340-5. doi: 10.1038/nature12586. Epub 2013 Sep 11.

PMID:
24025773
14.

Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.

Iglesias-García O, Pelacho B, Prósper F.

J Mol Cell Cardiol. 2013 Sep;62:43-50. doi: 10.1016/j.yjmcc.2013.04.022. Epub 2013 Apr 30. Review.

PMID:
23643470
15.

Amniotic fluid and placental stem cells.

Delo DM, De Coppi P, Bartsch G Jr, Atala A.

Methods Enzymol. 2006;419:426-38. Review.

PMID:
17141065
16.

Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.

Qin H, Blaschke K, Wei G, Ohi Y, Blouin L, Qi Z, Yu J, Yeh RF, Hebrok M, Ramalho-Santos M.

Hum Mol Genet. 2012 May 1;21(9):2054-67. doi: 10.1093/hmg/dds023. Epub 2012 Jan 27.

17.

Rapid and highly efficient generation of induced pluripotent stem cells from human umbilical vein endothelial cells.

Panopoulos AD, Ruiz S, Yi F, Herrerías A, Batchelder EM, Izpisua Belmonte JC.

PLoS One. 2011;6(5):e19743. doi: 10.1371/journal.pone.0019743. Epub 2011 May 16.

18.

Efficient generation of fully reprogrammed human iPS cells via polycistronic retroviral vector and a new cocktail of chemical compounds.

Zhang Z, Gao Y, Gordon A, Wang ZZ, Qian Z, Wu WS.

PLoS One. 2011;6(10):e26592. doi: 10.1371/journal.pone.0026592. Epub 2011 Oct 26. Erratum in: PLoS One. 2012;7(9). doi: 10.1371/annotation/2a5e8c51-2ad9-47c7-a4dd-9c9616bab32a.

19.

Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells.

Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, Miller JD, Hartung O, Rho J, Ince TA, Daley GQ, Schlaeger TM.

Nat Biotechnol. 2009 Nov;27(11):1033-7. doi: 10.1038/nbt.1580. Epub 2009 Oct 11.

PMID:
19826408
20.

Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage.

Medvedev SP, Grigor'eva EV, Shevchenko AI, Malakhova AA, Dementyeva EV, Shilov AA, Pokushalov EA, Zaidman AM, Aleksandrova MA, Plotnikov EY, Sukhikh GT, Zakian SM.

Stem Cells Dev. 2011 Jun;20(6):1099-112. doi: 10.1089/scd.2010.0249. Epub 2010 Oct 17.

PMID:
20846027
Items per page

Supplemental Content

Write to the Help Desk